Company & Sponsor Intelligence

Region Skane

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting3

Completed3

Countries2

Therapeutic footprint

autismeating_disordersepilepsyother_psychiatrystroke

Indexed studies

NCT05867940Effects of Physical Activity on Prescription (PAP) as a Health-enhancing Intervention in People With Disabilities
autism · SwedenNA

NCT07169747Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
eating_disorders · SwedenPHASE2

NCT06429332International Care Bundle Evaluation in Cerebral Hemorrhage Research
stroke · United StatesPHASE4

NCT03627663DBT-SS for Cognitively Challenged Individuals With Deliberate Self-harm
other_psychiatry · SwedenNA

NCT07373431Biomarkers for Epilepsy Development and the Effect of Physical Exercise in Children With Autism
epilepsy · SwedenNA

NCT04962373Brief Admission for Adolescents Who Self-harm
other_psychiatry · SwedenCOMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →